Immediate Impact
2 from Science/Nature 61 standout
Citing Papers
Diabetic Vasculopathy: Molecular Mechanisms and Clinical Insights
2024 Standout
Overall survival with sacituzumab govitecan in hormone receptor-positive and human epidermal growth factor receptor 2-negative metastatic breast cancer (TROPiCS-02): a randomised, open-label, multicentre, phase 3 trial
2023 Standout
Works of Young Up Cho being referenced
Intermediate HER2 expression is associated with poor prognosis in estrogen receptor-positive breast cancer patients aged 55 years and older
2019
Prevalence and Characteristics of Major Vascular Diseases of Elderly Men in the Incheon Area
2010
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Young Up Cho | 367 | 370 | 278 | 71 | 838 | |
| Cihangir Özaslan | 355 | 425 | 303 | 64 | 873 | |
| Il Yong Chung | 423 | 217 | 385 | 100 | 946 | |
| M Blichert-Toft | 246 | 331 | 367 | 63 | 858 | |
| Sergio Sandrucci | 299 | 478 | 315 | 54 | 853 | |
| Finn Ole Larsen | 530 | 234 | 102 | 49 | 843 | |
| Serdar Özbaş | 205 | 378 | 240 | 41 | 709 | |
| Laurence Digue | 337 | 247 | 184 | 57 | 897 | |
| Anita Skandarajah | 247 | 348 | 117 | 55 | 784 | |
| P Rissanen | 358 | 128 | 205 | 58 | 938 | |
| Christopher J. Magarey | 192 | 414 | 252 | 36 | 834 |
All Works
Login with ORCID to disown or claim papers
Loading papers...